We applied the miRCURY LNA microarray platform to generate miRNA expression profiles of breast cancer tissue and normal adjacent breast tissue to identify possible new biomarkers for breast cancer 9.

相关论文发表在7月15日的《癌症研究》（Cancer Research）杂志上。 来自剑桥大学的科学家们在新 ... 来自杜克大学医学中心、上海第二军医大学等处的研究人员在新研究中揭示了一个乳腺癌抑制microRNA对的确切功能和分子作用机制。这一研究成果或将促使研究人员 ...

A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...

Unlike expensive, invasive and risky tissue biopsies, the biomarkers found in body fluids, such as blood, urine or cerebral spinal fluid, offer an easier way to spot the first signs of cancer or ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

The US$40 million synthetic royalty-backed financing provided by R-Bridge is long-term with flexible and customized repayment schedule to meet Mirxes' near-term strategic priorities. Proceeds from the ...

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes ...

Mirxes, a leading Singapore-based cancer detection firm, has secured $40 million in financing from CBC Group's R-Bridge Fund to enhance its innovative miRNA technology platform. The investment aims to ...